Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Microba Life Sciences Limited (AU:MAP)
:MAP
RESEARCH TOOLSreports
MAP Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.15 - AU$0.33
Previous CloseN/A
Volume476.46K
Average Volume (3M)305.93K
Market Cap
AU$111.96M
Enterprise ValueAU$52.35M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.34
Next Earnings
Aug 27, 2025EPS Estimate
-0.02Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.05
Shares Outstanding447,852,000
10 Day Avg. Volume177,136
30 Day Avg. Volume305,929
Standard Deviation0.24
R-Squared0.23
Alpha0.00070
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)20.48
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.36Price Target Upside38.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
Microba Life Sciences Limited News
PremiumCompany Announcements
Microba Life Sciences Announces Securities CessationPremiumCompany Announcements
Microba Life Sciences Engages Stakeholders with Q2 FY25 Investor Webinar
PremiumCompany Announcements
Microba Life Sciences Reports Strong Q2 FY25 Growth
PremiumCompany Announcements
Mercer Investments Acquires Stake in Microba Life Sciences
PremiumCompany Announcements
Microba Life Sciences Updates Constitution to Boost InnovationPremiumCompany Announcements
Microba Life Sciences Advances with Key Resolutions Passed
PremiumCompany Announcements
Microba Life Sciences Eyes Growth in Diagnostics Market---
Options Prices
Currently, No data available
---
Ownership Overview
MAP FAQ
What was Microba Life Sciences Limited’s price range in the past 12 months?
Microba Life Sciences Limited lowest share price was AU$0.14 and its highest was AU$0.33 in the past 12 months.
What is Microba Life Sciences Limited’s market cap?
Microba Life Sciences Limited’s market cap is AU$111.96M.
When is Microba Life Sciences Limited’s upcoming earnings report date?
Microba Life Sciences Limited’s upcoming earnings report date is Aug 27, 2025 which is in 186 days.
How were Microba Life Sciences Limited’s earnings last quarter?
Currently, no data Available
Is Microba Life Sciences Limited overvalued?
According to Wall Street analysts Microba Life Sciences Limited’s price is currently Undervalued.
Does Microba Life Sciences Limited pay dividends?
Microba Life Sciences Limited does not currently pay dividends.
What is Microba Life Sciences Limited’s EPS estimate?
Microba Life Sciences Limited’s EPS estimate is -0.02.
How many shares outstanding does Microba Life Sciences Limited have?
Microba Life Sciences Limited has 447,852,000 shares outstanding.
What happened to Microba Life Sciences Limited’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Microba Life Sciences Limited?
Currently, no hedge funds are holding shares in AU:MAP
---
Microba Life Sciences Limited Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.36 (38.46% Upside)
AU$0.36 (38.46% Upside)
Blogger Sentiment
Bullish
AU:MAP Sentiment 70%
Sector Average 70%
Sector Average 70%
Insider Transactions
Bought Shares
Worth AU$67.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
38.88%
12-Months-Change
Fundamentals
Return on Equity
-49.98%
Trailing 12-Months
Asset Growth
23.61%
Trailing 12-Months
Company Description
Microba Life Sciences Limited
Microba Life Sciences Ltd is a commercial-stage company with leading technology for measuring the human gut microbiome which includes delivering gut microbiome testing services globally to consumers, clinicians, and researchers.
---
MAP Stock 12 Month Forecast
Average Price Target
AU$0.36
▲(38.46% Upside)
Technical Analysis
Biotron Limited
―
Immutep Ltd
―
Develop Global Limited
―
PYC Therapeutics Limited
―
Race Oncology Ltd.
―
Best Analysts Covering MAP
1 Year
1 Year Success Rate
2/5 ratings generated profit
1 Year Average Return
+3.60%
reiterated a buy rating 24 days ago
Copying Thomas Wakim's trades and holding each position for 1 Year would result in 40.00% of your transactions generating a profit, with an average return of +3.60% per trade.
---